Professor Sungmin Son from the Bio and Brain Engineering department at KAIST heads the first Korean team to utilize the cutting-edge STYX platform, developed by Atrandi Biosciences, in creating high-throughput technologies for analyzing molecular and cellular characteristics at the individual level.
As remarked by Ambassador of Lithuania to South Korea, Ricardas Slepavicius, this partnership with Atrandi Biosciences, a company based in Lithuania, highlights the growing collaboration between South Korea and Lithuania in the biotech sector.
We want to also acknowledge 신진연구자 인프라 지원 사업 for supporting this.